Publications

Tscharntke LT, Jung N, Hanses F, Koll CEM, Pil­gram L, Rieg S, Borgmann S, de Mir­anda SMN, Scher­er M, Spin­ner CD, Rüthrich M, Vehreschild MJGT, von Bergwelt-Bail­don M, Wille K, Merle U, Hower M, Roth­fuss K, Nadal­in S, Klinker H, Fürst J, Gre­if­fen­dorf I, Raichle C, Friedrichs A, Rauschning D, de With K, Eber­wein L, Riedel C, Milovan­ovic M, Worm M, Schul­the­is B, Schubert J, Bota M, Beutel G, Glück T, Schmid M, Win­ter­man­tel T, Peetz H, Stein­er S, Ribel E, Schäfer H, Vehreschild JJ, Stech­er M; LEOSS Study Group. Role and bene­fits of infec­tious dis­eases spe­cial­ists in the COVID-19 pan­dem­ic: Mul­ti­level ana­lys­is of care pro­vi­sion in Ger­man hos­pit­als using data from the Lean European Open Sur­vey on SARS-CoV­‑2 infec­ted patients (LEOSS) cohort. Infec­tion. 2024 Aug 16. doi: 10.1007/s15010-024–02362‑2. Epub ahead of print. PMID: 39150640.

Stell­mach C, Hopff SM, Jaen­isch T, Nunes de Mir­anda SM, Rinaldi E; NAPKON, LEOSS, ORCHESTRA, and ReCoDID Work­ing Groups. Cre­ation of Stand­ard­ized Com­mon Data Ele­ments for Dia­gnost­ic Tests in Infec­tious Dis­ease Stud­ies: Semant­ic and Syn­tact­ic Map­ping. J Med Inter­net Res. 2024 Jun 10;26:e50049. doi: 10.2196÷50049. PMID: 38857066; PMCID: PMC11196918.

Has­seli R, Hanses F, Stech­er M, Speck­er C, Weise T, Borgmann S, Has­sel­ber­ger M, Her­ten­stein B, Hower M, Hoy­er BF, Koll C, Krause A, von Lili­en­feld-Toal M, Lorenz HM, Merle U, Nunes de Mir­anda SM, Pletz MW, Regier­er AC, Richter JG, Rieg S, Roemmele C, Ruethrich MM, Schmeiser T, Schulze-Koops H, Strang­feld A, Vehreschild MJGT, Voit F, Voll RE, Vehreschild JJ, Müller-Lad­ner U, Pfeil A. The pro­tect­ive effect of tumor nec­ros­is factor-alpha inhib­it­ors in COVID-19 in patients with inflam­mat­ory rheum­at­ic dis­eases com­pared to the gen­er­al population‑A com­par­is­on of two Ger­man regis­tries. Front Med (Lausanne). 2024 Mar 6;11:1332716. doi: 10.3389/fmed.2024.1332716. PMID: 38510457; PMCID: PMC10953502.

Rüthrich MM, Khodamor­adi Y, Lan­znas­ter J, Stech­er M, Tometten L, Voit F, Koll CEM, Borgmann S, Vehreschild JJ, Ole Jensen BE, Hanses F, Giessen-Jung C, Wille K, von Lili­en­feld-Toal M, Beutel G; LEOSS Study Group. COVID-19 in Patients with Act­ive Can­cer: High­er Inflam­mat­ory Activ­ity Pre­dicts Poor Out­come. Oncol Res Treat. 2024;47(3):88–96. doi: 10.1159÷000535267. Epub 2023 Nov 15. PMID: 37967545.

Bartensch­la­ger CC, Grieger M, Erber J, Neidel T, Borgmann S, Vehreschild JJ, Stein­brech­er M, Rieg S, Stech­er M, Dhil­lon C, Ruethrich MM, Jakob CEM, Hower M, Heller AR, Vehreschild M, Wyen C, Mess­mann H, Piepel C, Brun­ner JO, Hanses F, Römmele C; LEOSS study group. Cov­id-19 triage in the emer­gency depart­ment 2.0: how ana­lyt­ics and AI trans­form a human-made algorithm for the pre­dic­tion of clin­ic­al path­ways. Health Care Man­ag Sci. 2023 Sep;26(3):412–429. doi: 10.1007/s10729-023–09647‑2. Epub 2023 Jul 10. PMID: 37428304; PMCID: PMC10485125.

Bartensch­la­ger CC, Ebel SS, Kling S, Vehreschild J, Zabel LT, Spin­ner CD, Schuler A, Heller AR, Borgmann S, Hoff­mann R, Rieg S, Mess­mann H, Hower M, Brun­ner JO, Hanses F, Römmele C. COVIDAL: A Machine Learn­ing Clas­si­fi­er for Digit­al COVID-19 Dia­gnos­is in Ger­man Hos­pit­als. ACM Trans. Man­age. Inf. Syst. 2023 Mar;14(2):14. doi.org/10.1145/3567431.

de Hes­selle ML, Borgmann S, Rieg S, Vehreschild JJ, Rasch S, Koll CEM, Hower M, Stech­er M, Ebert D, Hanses F, Schu­mann J, On Behalf Of The Leoss Study Group. Age and Comor­bid­ity Bur­den of Patients Crit­ic­ally Ill with COVID-19 Affect Both Access to and Out­come of Vent­il­a­tion Ther­apy in Intens­ive Care Units. J Clin Med. 2023 Mar 24;12(7):2469. doi: 10.3390/jcm12072469. PMID: 37048553; PMCID: PMC10095412.

Mas­caro S, Wu Y, Wood­berry O, Nyberg EP, Pear­son R, Ram­say JA, Mace AO, Foley DA, Snelling TL, Nich­olson AE; COVID BN Advis­ory Group. Mod­el­ing COVID-19 dis­ease pro­cesses by remote eli­cit­a­tion of caus­al Bayesian net­works from med­ic­al experts. BMC Med Res Meth­odol. 2023 Mar 29;23(1):76. doi: 10.1186/s12874-023–01856‑1. PMID: 36991342; PMCID: PMC10050813.

Schmidt-Hellerau K, Raichle C, Ruethrich MM, Vehreschild JJ, Lan­znas­ter J, Nunes de Mir­anda SM, Bause­wein C, Vehreschild MJGT, Koll CEM, Simon ST, Hell­wig K, Jensen BO, Jung N; LEOSS Study Group. Spe­cial­ized pal­li­at­ive care for hos­pit­al­ized patients with SARS-CoV­‑2 infec­tion: an ana­lys­is of the LEOSS registry. Infec­tion. 2023 Aug;51(4):1119–1126. doi: 10.1007/s15010-023–02020‑z. Epub 2023 Mar 23. PMID: 36952127; PMCID: PMC10034879.

Koppe U, Schilling J, Stech­er M, Rüthrich MM, Mar­quis A, Dier­cke M, Hasel­ber­ger M, Koll CEM, Niebank M, Ruehe B, Borgmann S, Graben­hen­rich L, Hell­wig K, Pil­gram L, Spin­ner CD, Paerisch T; LEOSS study group. Dis­ease sever­ity in hos­pit­al­ized COVID-19 patients: com­par­ing routine sur­veil­lance with cohort data from the LEOSS study in 2020 in Ger­many. BMC Infect Dis. 2023 Feb 10;23(1):89. doi: 10.1186/s12879-023–08035‑z. PMID: 36765274; PMCID: PMC9912207.

Pil­gram L, Appel KS, Ruethrich MM, Koll CEM, Vehreschild MJGT, de Mir­anda SMN, Hower M, Hell­wig K, Hanses F, Wille K, Hasel­ber­ger M, Spin­ner CD, Vom Dahl J, Her­ten­stein B, West­hoff T, Vehreschild JJ, Jensen BO, Stech­er M. Use and effect­ive­ness of rem­desivir for the treat­ment of patients with cov­id-19 using data from the Lean European Open Sur­vey on SARS-CoV­‑2 infec­ted patients (LEOSS): a mul­ti­centre cohort study. Infec­tion. 2023 Aug;51(4):1033–1049. doi: 10.1007/s15010-023–01994‑0. Epub 2023 Feb 10. PMID: 36763285; PMCID: PMC9913009.

Fre­ise NF, Gliga S, Fisc­her J, Lüb­ke N, Lut­ter­be­ck M, Schöler M, Bölke E, Orth HM, Feldt T, Roemmele C, Wilke D, Schneider J, Wille K, Hohmann C, Strauss R, Hower M, Ruf A, Schubert J, Isbern­er N, Stech­er M, Pil­gram L, Vehreschild JJ; LEOSS Study Group; Hanses F, Luedde T, Jensen B. Con­vales­cent plasma treat­ment for SARS-CoV­‑2 infec­ted high-risk patients: a matched pair ana­lys­is to the LEOSS cohort. Sci Rep. 2022 Nov 9;12(1):19035. doi: 10.1038/s41598-022–23200‑1. PMID: 36351986; PMCID: PMC9643921.

Heis­sig B, Salama Y, Iakoubov R, Vehreschild JJ, Rios R, Nogueira T, Vehreschild MJGT, Stech­er M, Mori H, Lan­znas­ter J, Ada­chi E, Jakob C, Tabe Y, Ruethrich M, Borgmann S, Naito T, Wille K, Valenti S, Hower M, Hat­tori N, Rieg S, Nagaoka T, Jensen BE, Yot­suyanagi H, Her­ten­stein B, Ogawa H, Wyen C, Kom­i­n­ami E, Roemmele C, Taka­hashi S, Rupp J, Taka­hashi K, Hanses F, Hat­tori K; LEOSS Study Group. COVID-19 Sever­ity and Thrombo-Inflam­mat­ory Response Linked to Eth­ni­city. Bio­medi­cines. 2022 Oct 12;10(10):2549. doi.org/10.3390/biomedicines10102549.

de Hes­selle ML, Borgmann S, Rieg S, Vehreshild JJ, Spin­ner CD, Koll CEM, Hower M, Stech­er M, Ebert D, Hanses F, Schu­mann J; LEOSS Study Group. Invas­ive­ness of Vent­il­a­tion Ther­apy Is Asso­ci­ated to Pre­val­ence of Sec­ond­ary Bac­teri­al and Fungal Infec­tions in Crit­ic­ally Ill COVID-19 Patients. J Clin Med. 2022 Sep 5;11(17):5239. doi: 10.3390/jcm11175239. PMID: 36079168; PMCID: PMC9457079.

Raichle C, Borgmann S, Bause­wein C, Rieg S, Jakob CEM, Simon ST, Tometten L, Vehreschild JJ, Leisse C, Erber J, Stech­er M, Pauli B, Rüthrich MM, Pil­gram L, Hanses F, Isbern­er N, Hower M, Degen­hardt C, Her­ten­stein B, Vehreschild MJGT, Römmele C, Jung N; LEOSS Study Group. Hos­pit­al­ized patients dying with SARS-CoV­‑2 infec­tion-An ana­lys­is of patient char­ac­ter­ist­ics and man­age­ment in ICU and gen­er­al ward of the LEOSS registry. PLoS One. 2022 Jul 29;17(7):e0271822. doi: 10.1371/journal.pone.0271822. PMID: 35905129; PMCID: PMC9337665.

Stefan N, Sip­pel K, Heni M, Fritsche A, Wag­n­er R, Jakob CEM, Preißl H, Wer­der A, Khodamor­adi Y, Borgmann S, Rüthrich MM, Hanses F, Hasel­ber­ger M, Piepel C, Hower M, vom Dahl J, Wille K, Römmele C, Vehreschild JJ, Stech­er M, Solimena M, Roden M, Schür­mann A, Gall­witz B, Hrabe de Angel­is M, Lud­wig DS, Schulze MB, Jensen BEO, Birken­feld A, on behalf of the LEOSS Study Group. Obesity and impaired meta­bol­ic health increase the risk of COV­ID-19-related mor­tal­ity in young and middle-aged adults to the risk level observed in eld­erly people; the LEOSS registry. Fron­ti­ers in Medi­cine. 2022 May 11. doi: 10.3389/fmed.2022.875430.

Pil­gram L, Eber­wein L, Jensen BEO, Jakob CM, Koehler FC, Hower M, Kiel­stein JT, Stech­er M, Hohen­stein B, Prass­er F, West­hoff T„ Nunes de Mir­anda SM, Vehreschild MJGT, Lan­znas­ter J, Dolff S, LEOSS study group. SARS-CoV­‑2 infec­tion in chron­ic kid­ney dis­ease patients with pre-exist­ing dia­lys­is: descrip­tion across dif­fer­ent pan­dem­ic inter­vals and effect on dis­ease course (mor­tal­ity). Infec­tion. 2022. Apr 29. 1–11.

Broz­at JF, Hanses F, Hael­ber­ger M, Stech­er M, Dre­her M, Tometten L, Ruethrich MM, Vehreschild JJ, Traut­wein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stall­mach A, Wille K, Hell­wig K, Isbern­er N, Reuk­en PA, Geisler F, Nat­ter­mann J, Bruns T, the LEOSS study. COVID-​19 mor­tal­ity in cir­rhosis is determ­ined by cirrhosis-​associated comor­bid­it­ies and extra­hep­at­ic organ fail­ure: Res­ults from the mul­tina­tion­al LEOSS registry. United European Gast­roen­ter­o­logy Journ­al, 1–16. 2022 Apr 28, doi: 10.1002/ueg2.12232.

Linden T, Hanses F, Fernán­dez DD, DeLong LN, Koda­mul­lil AT, Schneider J, Vehreschild MJGT, Lan­znas­ter J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Her­ten­stein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stech­er M, Kuzikov M, Zaliani A, Fröh­lich H, LEOSS study group. Machine learn­ing based pre­dic­tion of COVID-19 mor­tal­ity sug­gests repos­i­tion­ing of anti­c­an­cer drug for treat­ing severe cases. 2021 Nov 12. Arti­fi­cial Intel­li­gence in the Life Sci­ences doi: 10.1101/2021.11.11.21266048.

Pil­gram L, Schons M, Jakob CM, Claßen AY, Franke B, Tscharntke L, Schulze N, Fuhr­mann S, Sauer G, Nunes de Mir­anda SM, Prass­er F, Stech­er M, Vehreschild JJ, : The COVID-19 pan­dem­ic as an oppor­tun­ity and chal­lenge for regis­tries in health ser­vices research: Les­sons learned in the Lean European Open Sur­vey on SARS-CoV­‑2 Infec­ted Patients (LEOSS). Gesund­heit­swesen 2021 Nov 3; 83(S 01): S45-S53. doi: 10.1055/a‑1655–8705.

Cre­mer S, Pil­gram L, Berkow­itsch A, Stech­er M, Rieg S, Shum­liakivska M, Bojkova D,
Wag­n­er JUG, Ser­vet Aslan G, Spin­ner C, Lux­an G, Hanses F, Dolff S, Piepel C, Rup­pert C, Guen­ther A, Rüthrich MM, Vehreschild JJ, Wille K, Hasel­ber­ger M, Heuzeroth H, Hansen A, Eschen­ha­gen T, Cin­atl J, Ciesek S, Dimmel­er S, Borgmann S, Zei­h­er A, LEOSS study group. Angiotensin II recept­or block­er intake asso­ci­ates with reduced mark­ers of inflam­mat­ory activ­a­tion and decreased mor­tal­ity in patients with car­di­ovas­cu­lar comor­bid­it­ies and COVID-19 dis­ease. PLOS One. 2021 Oct 21 doi:/10.1371/journal.pone.0258684.

Zellmer S, Hanses F, Muzalyova A, Classen J, Braun G, Piepel C, Erber J, Pil­gram L, Wal­ter L, Göpel S, Wille K, Hower M, Rüthrich MM, Rupp J, Degen­hardt C, Voigt I, Borgmann S, Stech­er M, Jakob C, Dhil­lon C, Mess­mann H, Ebigbo A, Römmele C; LEOSS study group. Gastrointest­in­al bleed­ing and endo­scop­ic find­ings in crit­ic­ally and non-crit­ic­ally ill patients with corona vir­us dis­ease 2019 (COVID-19): Res­ults from Lean European Open Sur­vey on SARS-CoV­‑2 (LEOSS) and COKA regis­tries. United European Gast­roen­ter­ol J. 2021 Oct 15. doi: 10.1002/ueg2.12165. PMID: 34655180 DOI: 10.1002/ueg2.12165.

Schons MJ, Caliebe A, Spin­ner CD, Classen AY, Pil­gram L, Ruethrich MM, Rupp J, Nunes de Mir­anda SM, Römmele C, Vehreschild J, Jensen BE, Vehreschild M, Degen­hardt C, Borgmann S, Hower M, Hanses F, Hasel­ber­ger M, Friedrichs AK; LEOSS-study group. All-cause mor­tal­ity and dis­ease pro­gres­sion in SARS-CoV-2-infec­ted patients with or without anti­bi­ot­ic ther­apy: an ana­lys­is of the LEOSS cohort. Infec­tion. 2021 Oct 8:1–14. doi: 10.1007/s15010-021–01699‑2.

Rieder M, Gauchel N, Kaier K, Jakob C, Borgmann S, Classen AY, Schneider J, Eber­wein L, Lab­lans M, Rüthrich M, Dolff S, Wille K, Hasel­ber­ger M, Heuzeroth H, Bode C, von Zur Müh­len C, Rieg S, Duer­schmied D. Pre-med­ic­a­tion with oral anti­co­agu­lants is asso­ci­ated with bet­ter out­comes in a large mul­tina­tion­al COVID-19 cohort with car­di­ovas­cu­lar comor­bid­it­ies. Clin Res Car­di­ol. 2021 Sep 21:1–11. doi: 10.1007/s00392-021–01939‑3. Epub ahead of print. PMID: 34546427; PMCID: PMC8453472.

Mein­trup D, Borgmann S, Seidl K, Stech­er M, Jakob CEM, Pil­gram L, Spin­ner CD, Rieg S, Isbern­er N, Hower M, Vehreschild M, Göpel S, Hanses F, Nowak-Machen M, LEOSS Study Group. Spe­cif­ic Risk Factors for Fatal Out­come in Crit­ic­ally Ill COVID-19 Patients: Res­ults from a European Mul­ti­cen­ter Study. J. Clin. Med. 2021, 10(17), 3855; doi.org/10.3390/jcm10173855.

Kleine­berg NN, Knauss S, Gülke E, Pinnschmidt HO, Jakob CEM, Lingor P, Hell­wig K, Ber­thele A, Höglinger G, Fink GR, Endres M, Ger­loff C, Klein C, Stech­er M, Classen AY, Rieg S, Borgmann S, Hanses F, Rüthrich MM, Hower M, Tometten L, Hasel­ber­ger M, Piepel C, Merle U, Dolff S, Degen­hardt C, Jensen BEO, Vehreschild M, Erber J, Franke C, Warnke C, LEOSS Study Group. Neur­o­lo­gic­al symp­toms and com­plic­a­tions in pre­dom­in­antly hos­pit­al­ized COVID-19 patients – res­ults of the European mul­tina­tion­al LEOSS registry. Eur J Neur­ol. 2021 Aug 9. doi: 10.1111/ene.15072.

Kühn MJ, Abele D, Mitra T, Koslow W, Abedi M, Rack K, Siggel M, Khail­aie S, Klitz M, Bind­er S, Spataro L, Gilg J, Klein­ert J, Häberle M, Plötzke L, Spin­ner CD, Stech­er M, Zhu XX, Baser­mann A, Mey­er-Her­mann M. Assess­ment of effect­ive mit­ig­a­tion and pre­dic­tion of the spread of SARS-CoV­‑2 in Ger­many using demo­graph­ic inform­a­tion and spa­tial res­ol­u­tion. Math­em­at­ic­al Bios­ciences. 2021, Volume 339, Art­icle 108648. doi: 10.1016/j.mbs.2021.108648.

Wer­fel S, Jakob CEM, Borgmann S, Schneider J, Spin­ner C, Schons M, Hower M, Wille K, Hasel­ber­ger M7, Heuzeroth H8, Rüthrich MM, Dolff S, Kes­sel J, Heemann U, Vehreschild JJ, Rieg S, Schma­der­er C1, LEOSS study group. Devel­op­ment and Val­id­a­tion of a Sim­pli­fied Risk Score for the Pre­dic­tion of Crit­ic­al COVID-19 Ill­ness in Newly Dia­gnosed Patients. Journ­al of Med­ic­al Vir­o­logy, 31 Jul 2021. doi: 10.1002/jmv.27252. PMID: 34331717. PMCID: PMC8426905.

Jakob CEM, Mahajan Mukund U, Oswald M, Stech­er M, Schons M, May­erle J, Rieg S, Pletz M, Merle U, Wille K, Borgmann S, Spin­ner CD, Dolff S, Scher­er C, Pil­gram L, Rüthrich M, Hanses F, Hower M, Strauß R, Mass­berg S, Er Görkem A, Jung N, Vehreschild J J, Stubbe H, Tometten L, König R; LEOSS Study Group. Pre­dic­tion of COVID-19 deteri­or­a­tion in high-risk patients at dia­gnos­is: an early warn­ing score for advanced COVID-19 developed by machine learn­ing. Infec­tion. 2021 Jul 13. doi: 10.1007/s15010-021–01656‑z.

Pil­gram L, Eber­wein L, Wille K, Koehler FC, Stech­er M, Rieg S, Kiel­stein JT, Jakob CEM, Rüthrich M, Burst V, Prass­er F, Borgmann S, Müller RU, Lan­znas­ter J, Isbern­er N, Tometten L, Dolff S; LEOSS Study group. Clin­ic­al course and pre­dict­ive risk factors for fatal out­come of SARS-CoV­‑2 infec­tion in patients with chron­ic kid­ney dis­ease. Infec­tion. 2021 Apr 13. doi: 10.1007/s15010-021–01597‑7. Epub ahead of print. PMID: 33851328.

Huber, M.K., Raichle, C., Lingor, P., Syn­ofzik, M., Borgmann, S., Erber, J., Tometten, L., Rimili, W., Dolff, S., Wille, K., Knauss, S., Piepel, C., Lan­znas­ter, J., Rieg, S., Prass­er, F., Pil­gram, L., Spot­tke, A., Klock­geth­er, T., Klein, C., Hop­fn­er, F., Höglinger, G.U. and (2021), Out­comes of SARS-​CoV-​2 Infec­tions in Patients With Neuro­de­gen­er­at­ive Dis­eases in the LEOSS Cohort. Mov Dis­ord, 2021 Feb­ru­ary 17. doi: 10.1002/mds.28554.

Jakob CEM, Kohl­may­er F, Meur­ers T, Vehreschild JJ, Prass­er F. Design and eval­u­ation of a data anonym­iz­a­tion pipeline to pro­mote Open Sci­ence on COVID-19. Sci Data. 2020 Dec 10;7(1):435. doi: 10.1038/s41597-020–00773‑y. PMID: 33303746; PMCID: PMC7729909.

Cre­mer S, Jakob C, Berkow­itsch A, Borgmann S, Pil­gram L, Tometten L,  Classen A, Wille K, Weid­lich S, Gruen­er B, Dimmel­er S, Mass­berg S, Rieg  S, Zei­h­er AM; LEOSS study group. Elev­ated mark­ers of thrombo-inflam­mat­ory activ­a­tion pre­dict out­come in patients with car­di­ovas­cu­lar comor­bid­it­ies and COVID-19 dis­ease: insights from the LEOSS registry. Clin Res Car­di­ol. 2020 Nov 19:1–12. doi: 10.1007/s00392-020–01769‑9. Epub ahead of print. PMID: 33211155; PMCID:  PMC7674577.

Hugo C, Strass­burg C, Stech­er M, Rah­mel A. Stable and safe organ pro­cure­ment and trans­plant­a­tion dur­ing SARS-CoV­‑2 pan­dem­ic in Ger­many. Trans­pl Int. 2020 Oct;33(10):1335–1336. doi: 10.1111/tri.13704. Epub  2020 Aug 12. PMID: 32697364; PMCID: PMC7405468.

Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grün­er B, Hanses F, Isbern­er N, Köhler P, Lan­znas­ter J, Merle U, Nadal­in S, Piepel C, Schneider J, Schons M, Strauss R, Tometten L, Vehreschild JJ, von Lili­en­feld-Toal M, Beutel G, Wille K; LEOSS Study Group. COVID-19 in can­cer patients: clin­ic­al char­ac­ter­ist­ics and out­come – an ana­lys­is of the LEOSS registry. Ann Hem­at­ol. 2020 Nov 7:1–11. doi: 10.1007/s00277-020–04328‑4. Epub ahead of print. PMID: 33159569; PMCID: PMC7648543.

Jakob CEM, Borgmann S, Duy­gu F, Behrends U, Hower M, Merle U, Friedrichs A, Tometten L, Hanses F, Jung N, Rieg S, Wille K, Grün­er B, Klinker H, Gers­bach­er-Runge N, Hell­wig K, Eber­wein L, Dolff S, Rauschning D, von Bergwelt-Bail­don M, Lan­znas­ter J, Strauß R, Trau­th J, de With K, Ruethrich M, Lueck C, Nat­ter­mann J, Tscharntke L, Pil­gram L, Fuhr­mann S, Classen A, Stech­er M, Schons M, Spin­ner C, Vehreschild JJ. First res­ults of the “Lean European Open Sur­vey on SARS-CoV-2-Infec­ted Patients (LEOSS)”. Infec­tion. 2020 Oct 1:1–11. doi: 10.1007/s15010-020–01499‑0. Epub ahead of print. PMID: 33001409; PMCID: PMC7527665.

Schoser B, Baum P, Boen­tert M, Dill­mann K, Emmer A, Knauss S, Enax-Kru­mova E, Grosskreutz J,  Gütt­sches A,  Hell­wig K,  Holza­p­fel K, Korn­blum C, Lehmann H, Melms A,  Mey­er T,  Petri S, Pil­gram L, Rein­ers K,  Saak A, Schäfer J, Schmidt J, Schneider-Gold C, Schons M, Urb­an PP, Vor­gerd M, Young P, Zierz S. SARS-CoV­‑2/­COV­ID-19 und neur­omuskuläre Erkrankun­gen. DGNeur­o­lo­gie 3, 310–320. 2020 May 18. doi: 10.1007/s42451-020–00198‑2.